[INM] YoY Annual Result on 30-Jun-2020 [#FY]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
30-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#FY]
Profit Trend
YoY- 11.54%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Annual Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 4,136 1,089 0 0 0 0 0 -
PBT -7,935 -18,600 -10,203 -8,681 -10,097 -6,708 -3,440 14.93%
Tax 13 4,808 360 19 -262 -70 0 -
NP -7,948 -23,408 -10,563 -8,700 -9,835 -6,708 -3,440 14.97%
Tax Rate - - - - - - - -
Total Cost 12,083 24,498 10,563 8,700 9,835 6,708 3,440 23.28%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -192.18 -2,148.68 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -3.25 -41.74 -39.30 -41.66 -47.49 -38.85 -31.73 -31.58%
EPS Diluted -3.25 -41.74 -39.30 -41.66 -47.49 -38.85 -31.73 -31.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.